Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.29 USD | -2.92% | -6.08% | 0.00% |
04-15 | Leerink Partners Starts LENZ Therapeutics With Outperform Rating, $32 Price Target | MT |
04-15 | William Blair Starts LENZ Therapeutics With Outperform Rating | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
LENZ THERAPEUTICS, INC. | Bio Therapeutic Drugs | -2.92% | -6.08% | - | - | - | 441M | - | - | - |
- Stock Market
- Equities
- LENZ Stock
- Charts LENZ Therapeutics, Inc.
- Relative Strength Chart